INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)
Instituto
Boston University School of Medicine
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Boston University School of Medicine (5)
2024
-
Clinical relevance of intracranial hemorrhage after thrombectomy versus medical management for large core infarct: a secondary analysis of the SELECT2 randomized trial
Journal of NeuroInterventional Surgery, pp. 1-8
2022
-
A role for the circadian transcription factor NPAS2 in the progressive loss of non-rapid eye movement sleep and increased arousal during fentanyl withdrawal in male mice
Psychopharmacology, Vol. 239, Núm. 10, pp. 3185-3200
-
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)
Nature
-
Stroke genetics informs drug discovery and risk prediction across ancestries
Nature, Vol. 611, Núm. 7934, pp. 115-123
2021
-
Decline in subarachnoid haemorrhage volumes associated with the first wave of the COVID-19 pandemic
Stroke and Vascular Neurology, Vol. 6, Núm. 4, pp. 542-552